Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ligand Pharmaceuticals (LGND) Long-Term Deferred Tax (2016 - 2025)

Ligand Pharmaceuticals' Long-Term Deferred Tax history spans 14 years, with the latest figure at $8.3 million for Q4 2025.

  • For Q4 2025, Long-Term Deferred Tax rose 11490.28% year-over-year to $8.3 million; the TTM value through Dec 2025 reached $8.3 million, up 11490.28%, while the annual FY2025 figure was $8.3 million, 11490.28% up from the prior year.
  • Long-Term Deferred Tax for Q4 2025 was $8.3 million at Ligand Pharmaceuticals, down from $9.5 million in the prior quarter.
  • Across five years, Long-Term Deferred Tax topped out at $35.7 million in Q4 2021 and bottomed at $72000.0 in Q4 2024.
  • The 5-year median for Long-Term Deferred Tax is $8.5 million (2022), against an average of $14.3 million.
  • The largest annual shift saw Long-Term Deferred Tax plummeted 99.09% in 2024 before it soared 12112.82% in 2025.
  • A 5-year view of Long-Term Deferred Tax shows it stood at $35.7 million in 2021, then plummeted by 76.13% to $8.5 million in 2022, then plummeted by 97.49% to $214000.0 in 2023, then crashed by 66.36% to $72000.0 in 2024, then soared by 11490.28% to $8.3 million in 2025.
  • Per Business Quant, the three most recent readings for LGND's Long-Term Deferred Tax are $8.3 million (Q4 2025), $9.5 million (Q3 2025), and $829000.0 (Q2 2025).